وثيقة
Drug delivery of carvedilol (cardiovascular drug) using phosphorene as a drugcarrier : a DFT study
وكيل مرتبط
Afzal, Q.Q, مؤلف مشارك
Perveen, M, مؤلف مشارك
Iqbal, J, مؤلف مشارك
Akhter, M.S, مؤلف مشارك
Nazir, S, مؤلف مشارك
Al-Buriahi, M.S, مؤلف مشارك
Alomairy, S, مؤلف مشارك
Alrowaili, Z.A, مؤلف مشارك
عنوان الدورية
Journal of Taibah University for Science
دولة النشر
Kingdom of Bahrain
مكان النشر
Sakhir, Bahrain
الناشر
University of Bahrain
تاريخ النشر
2022
اللغة
إنجليزي
الموضوع
الملخص الإنجليزي
ABSTRACT:
2D nanomaterial phosphorene is a chemistically stable, biocompatible, and biodegradable drug delivery platform. This study investigates the drug loading efficiency of phosphorene for the car-diovascular drug carvedilol using density-functional theory (DFT). In the gas phase, carvedilol prefers to interact with phosphorene via P-H bonding with an adsorption energy of 0.59 eV (0.45eV in water). The complex HOMO–LUMO energy gap has been calculated in gas and solvent media to assess phosphorene-carvedilol reactivity. As compared to free carvedilol and phos-phorene, the phosphorene-carvedilol complex has increased solubility. The NCI analysis visu-alises non-covalent interactions within complexes. The low Van der Waals interactions between carvedilol and phosphorene allow for easy drug offloading. The phosphorene-carvedilol com-plex is more soluble in water than previously thought. Phosphorene’s electron density changes significantly after complex formation, as revealed by charge decomposition plots and electron-localization function plots. PET (photo-induced electron transfer) analysis explains quenching.
المجموعة
المعرف
https://digitalrepository.uob.edu.bh/id/4955f492-4408-4366-9622-f6fef612f1df
مواد أخرى لنفس الموضوع